Badanie skuteczności i bezpieczeństwa MORF-057 u dorosłych z umiarkowanie do ciężko aktywnym wrzodziejącym zapaleniem jelita grubego

Ulcerative colitis is a condition that causes inflammation and sores in the lining of the large intestine. This study focuses on adults with moderately to severely active ulcerative colitis. The treatment being tested is a capsule called MORF-057, which is taken by mouth. The main goal of the study is to see how well MORF-057 works in improving the condition of the intestine after 12 weeks of treatment.

The study will involve participants taking MORF-057 capsules for a period of time, with regular check-ups to monitor their health and the effects of the treatment. The study will also look at the safety and tolerability of the treatment, meaning it will check for any side effects or issues that might arise from taking the medication. Participants will be observed for changes in their condition and overall health during the study period.

Throughout the study, the effects of MORF-057 will be measured by looking at changes in specific scores that assess the severity of ulcerative colitis. These scores help doctors understand how the treatment is affecting the inflammation and overall condition of the intestine. The study aims to provide valuable information on whether MORF-057 can be an effective treatment option for people with this condition.